Found 15 matching trials
A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis
PHASE3This is a phase 3, open-label, randomized clinical trial in adults and adol...
Location
Perinatal HIV Research Unit, PHRU-Matlosana, Tshepong Hospital
Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches
PHASE1The objective of this clinical trial is to evaluate bioequivalence of "LCB0...
Location
Seoul National University Bundang Hospital
A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
PHASE1Primary
\- To investigate the safety and tolerability of LCB01-0371 after ...
Location
Asan Medical Center
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
PHASE2This trial is to describe the safety, tolerability and exposure-toxicity re...
Location
The Aurum Institute Tembisa Clinical Research Centre
IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers
PHASE1Primary - To investigate the Pharmacokinetics, Safety, and Tolerability of ...
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
PHASE2The UNITE4TB consortium is a group of universities and pharmaceutical compa...
Location
PMSI Institute of Pneumology "Chiril Draganiuc"
Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371
PHASE1The purpose of this study is to investigate the population pharmacokinetics...
Location
Seoul National University Bundang Hospital
A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK
PHASE2A Prospective, Randomized, Open, Active-controlled, Interventional, Explora...
Location
Asan Medical Center
Multiple Ascending Dose Study for LCB01-0371
PHASE1Primary
* To investigate the safety and tolerability of LCB01-0371 after a...
Location
Asan Medical Center
To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371
PHASE1The purpose of this study is to assess safety, tolerability of LCB01-0371 a...
Location
Seoul National University Bundang Hospital